The Venture Codex Logo

The Venture Codex

Aisling Capital

888 7th Avenue, 12th Floor, New York, NY, 10106, US

Overview

Investment firm supporting biotechnology and healthcare innovations.

Founded

2000

Deals ยท 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series B
Series C

Geographic focus

United States

Sector focus

Biotechnology
Health Care
Venture Capital

Investment portfolio

74rounds
NAMEDATESIZE
Claris Biotherapeutics
Jul 2026Participated
$118 MSeries B
Treeline Biosciences
Sep 2025Participated
$200 MSeries A
BridgeBio Oncology Therapeutics
May 2024Participated
$200 MOther Equity
Bicara Therapeutics
Dec 2023Participated
$165 MSeries C
COMPASS Pathways
Aug 2023Led
$285 MOther Equity
Garuda Therapeutics
Feb 2023Led
$62 MSeries B
Forge Biologics
Sep 2022Led
$90 MSeries C
Dren Bio
Jun 2022Led
$65 MSeries B
Antios Therapeutics
Nov 2021Participated
$75 MSeries B
Garuda Therapeutics
Sep 2021Led
$72 MSeries A
Antios Therapeutics
Apr 2021Participated
$96 MSeries B
Monte Rosa Therapeutics
Mar 2021Participated
$95 MSeries C
Claris Biotherapeutics
Jul 2026Participated
$118 MSeries B
Treeline Biosciences
Sep 2025Participated
$200 MSeries A
BridgeBio Oncology Therapeutics
May 2024Participated
$200 MOther Equity
Bicara Therapeutics
Dec 2023Participated
$165 MSeries C
COMPASS Pathways
Aug 2023Led
$285 MOther Equity
Garuda Therapeutics
Feb 2023Led
$62 MSeries B
Forge Biologics
Sep 2022Led
$90 MSeries C
Dren Bio
Jun 2022Led
$65 MSeries B
Antios Therapeutics
Nov 2021Participated
$75 MSeries B
Garuda Therapeutics
Sep 2021Led
$72 MSeries A
Antios Therapeutics
Apr 2021Participated
$96 MSeries B
Monte Rosa Therapeutics
Mar 2021Participated
$95 MSeries C
74
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Aisling Capital: 74 funding rounds are recorded in the selected participation categories.All available history.
Aisling Capital: 74 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A44
Series B315
Series C+721
Other Equity414
Debt02

Monthly Deal Activity

Aisling Capital: 74 deals are recorded across 233 months.All available history.
Aisling Capital: 74 deals are recorded across 233 months. All available history
MonthDeals
Jun '071
Jul '070
Aug '070
Sep '070
Oct '070
Nov '070
Dec '070
Jan '080
Feb '080
Mar '080
Apr '080
May '080
Jun '080
Jul '081
Aug '080
Sep '080
Oct '081
Nov '080
Dec '080
Jan '090
Feb '090
Mar '090
Apr '091
May '090
Jun '090
Jul '090
Aug '090
Sep '090
Oct '091
Nov '090
Dec '090
Jan '100
Feb '100
Mar '100
Apr '101
May '100
Jun '101
Jul '100
Aug '101
Sep '100
Oct '100
Nov '100
Dec '100
Jan '111
Feb '110
Mar '110
Apr '110
May '110
Jun '111
Jul '110
Aug '112
Sep '110
Oct '110
Nov '110
Dec '111
Jan '122
Feb '120
Mar '123
Apr '120
May '120
Jun '120
Jul '121
Aug '120
Sep '120
Oct '121
Nov '121
Dec '120
Jan '131
Feb '130
Mar '131
Apr '131
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '133
Nov '130
Dec '131
Jan '140
Feb '142
Mar '140
Apr '140
May '141
Jun '142
Jul '140
Aug '141
Sep '140
Oct '141
Nov '140
Dec '140
Jan '150
Feb '150
Mar '151
Apr '151
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '161
Feb '160
Mar '162
Apr '160
May '160
Jun '162
Jul '160
Aug '160
Sep '160
Oct '160
Nov '161
Dec '161
Jan '170
Feb '170
Mar '171
Apr '170
May '170
Jun '171
Jul '171
Aug '170
Sep '171
Oct '170
Nov '171
Dec '170
Jan '180
Feb '181
Mar '180
Apr '181
May '180
Jun '180
Jul '181
Aug '180
Sep '181
Oct '180
Nov '180
Dec '180
Jan '191
Feb '190
Mar '190
Apr '191
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '191
Nov '190
Dec '190
Jan '200
Feb '201
Mar '200
Apr '200
May '200
Jun '200
Jul '201
Aug '200
Sep '200
Oct '201
Nov '201
Dec '201
Jan '211
Feb '210
Mar '211
Apr '211
May '210
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '221
Oct '220
Nov '220
Dec '220
Jan '230
Feb '231
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '231
Sep '230
Oct '230
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '241
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '261
Aug '260
Sep '260
Oct '260

Sector Breakdown

Aisling Capital: Health & Life Sciences is the largest displayed sector by deal count (73 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Aisling Capital: Health & Life Sciences is the largest displayed sector by deal count (73 deals). All available history
SectorDeals
Health & Life Sciences73
Manufacturing5
Consumer & Lifestyle3
Hardware & Robotics2
E-Commerce & Retail1
Food & Agriculture1
Space & Frontier Tech1

Deal Size Distribution

Aisling Capital: 74 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Aisling Capital: 74 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M12
$25M-$50M23
$50M-$100M24
$100M-$250M11
$250M-$500M3
$500M-$1B0
$1B+0

Deals By Geography

Aisling Capital: United States has the largest recorded deal count among the displayed regions (71 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Aisling Capital: United States has the largest recorded deal count among the displayed regions (71 deals). All available history
RegionDeals
United States71
Europe3
Aisling Capital: 20 co-investors are shown, with OrbiMed sharing 16 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Aisling Capital: 20 co-investors are shown, with OrbiMed sharing 16 recorded deals. All available history
Co-investorShared deals
OrbiMed16
Cormorant Asset Management10
F-Prime Capital8
New Enterprise Associates7
RA Capital Management7
Rock Springs Capital7
Alexandria Venture Investments6
Kearny Venture Partners6
Surveyor Capital6
Amzak Health5
Boxer Capital5
Domain Associates5
Fidelity Management & Research Company5
Janus Henderson Investors5
KKR5
Longitude Capital5
Perceptive Advisors5
Polaris Partners5
Venrock5
Vivo Capital5

Investment Strategy

Aisling Capital: Led accounts for 24% and participating for 76% of round participation.All available history.
Aisling Capital: Led accounts for 24% and participating for 76% of round participation. All available history
CategoryDeals (count)Share (%)
Led1824%
Participating5676%
Aisling Capital: Single-lead accounts for 39% and co-led for 61% of lead dynamics.All available history.
Aisling Capital: Single-lead accounts for 39% and co-led for 61% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead739%
Co-led1161%

Team

Aftab Kherani

Operating Partner

Andrew Schiff

Managing Partner

Dennis Purcell

Founder & Senior Advisor

Eric Aguiar

Partner

Jan Hoerrner

Director of Investor Relations & Marketing

Scott Braunstein

Operating Partner

Stacey Seltzer

Partner

Steven A. Elms

Managing Partner